Tag Archives: Bloomberg

GOP Senate health bill finally unveiled; Republicans now can say at least they tried to scrap Obamacare.






A lot of Americans, including all but literally a handful of our elected representatives, have been sitting on pins and needles, waiting for the Senate to divulge its version of… Read more »

CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it






The News: Swiss drug giant Novartis AG has drawn widespread praise and a rising dose of controversy pertaining to its breakthrough CAR-T therapy CTL019. The medicine is under review to… Read more »

Tesaro says it’s for sale, but who can afford it






The News: Just ahead of the year’s biggest download of cancer data, the maker of a closely watched drug has put itself up for sale, according to The Wall Street… Read more »

Universal health care: a “right” or “privilege.” Wrong question, or already settled?






Steve’s Take: Bloomberg’s Ramesh Ponnuru poses the question: “Is there a ‘right’ to healthcare? Our arguments about health policy frequently highlight the question.” He goes on to say that “as… Read more »

Amgen’s osteoporosis med almost a home run in latest trial; fate now murky on heart safety






The News: Amgen Inc. (Thousand Oaks CA) and UCB SA (Brussels) no longer expect their experimental osteoporosis drug to win US approval this year after a higher rate of serious… Read more »

Surprise! GOP health bill never left the House






The News: The US House of Representatives will send its healthcare overhaul plan passed earlier this month to the Senate in a couple of weeks after it receives a final… Read more »

Merck’s Keytruda gets chemo-combo approval for lung cancer; science, stars align for multi-billion medicine






The News: Merck & Co. announced Wednesday (May 10, 2017) that the FDA awarded accelerated approval to Keytruda (pembrolizumab), in combination with Eli Lilly & Co.’s chemotherapy regimen Alimta (pemetrexed)… Read more »

Pfizer’s mixed 1Q results spur M&A hopes; is Bristol-Myers a “done deal”?






The News: Pfizer Inc. said Tuesday (May 2, 2017) that first-quarter sales declined 2% year-over-year to $12.8 billion, missing analyst estimates of $13.1 billion, with the company highlighting one less… Read more »

GOP healthcare bill heads to Senate where fate far from certain






The News: The US House of Representatives on Thursday (May 4, 2017) voted 217 to 213 in favor of proposed legislation that would repeal and replace parts of the Affordable Care Act (ACA), signed into… Read more »

NIH proves immune to Trump’s budget scalpel






The News: Lawmakers expanded instead of slashed the budget for the National Institutes of Health (NIH) in its bipartisan deal to fund the government earlier this week, essentially snubbing the… Read more »